Risks

Evidence: E2 — independently cross-checked across current U.S. FDA and eCFR materials, current manufacturer instructions, exact drug-label records, recall notices, and formulation-specific stability or in-use studies Risk scope: R1 — post-purchase documentation of product identity, package condition, storage directions, dates, handling, and visible change; no diagnosis, contamination finding, potency finding, reaction causation, or individualized safety … Read more

An ingredient list can show what is disclosed, but it cannot reveal exact amounts, formula quality, pH, stability, preservation performance, or a finished product’s safety or results.